Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study

References

• LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 2001;412(6850):877–884.
   PubMed Web of Science ®Google Scholar
• Soga T, Matsumoto Si, Oda T, et al. Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta. 2002;1579(2–3):173–179.
   PubMed Web of Science ®Google Scholar
• Brouillet S, Murthi P, Hoffmann P, et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell Mol Life Sci. 2013;70(3):511–525.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology. 2006;147(4):1675–1684.
   PubMed Web of Science ®Google Scholar
• Alfaidy N, Hoffmann P, Boufettal H, et al. The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis. BioMed Res Int. 2014;2014:451906.
   PubMed Web of Science ®Google Scholar
• Kirkegaard I, Uldbjerg N, Oxvig C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand. 2010;89(9):1118–1125.
   PubMed Web of Science ®Google Scholar
• Dunand C, Hoffmann P, Sapin V, et al. Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition. Biol Reprod. 2014;91(3):73.
   PubMed Web of Science ®Google Scholar
• McLaren J, Taylor DJ, Bell SC. Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol. 2000;182(2):409–416.
   PubMed Web of Science ®Google Scholar
• Patel FA, Challis JR. Cortisol/progesterone antagonism in regulation of 15-hydroxysteroid dehydrogenase activity and mRNA levels in human chorion and placental trophoblast cells at term. J Clin Endocrinol Metab. 2002;87(2):700–708.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Saoudi Y, Benharouga M, et al. Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med. 2009;13(8B):2224–2235.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
   PubMed Web of Science ®Google Scholar
• Duan J, Chabot-Lecoanet AC, Perdriolle-Galet E, et al. Utero-placental vascularisation in normal and preeclamptic and intra-uterine growth restriction pregnancies: third trimester quantification using 3D power Doppler with comparison to placental vascular morphology (EVUPA): a prospective controlled study. BMJ Open. 2016;6(3):e009909.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
   PubMed Web of Science ®Google Scholar
• Gelaleti RB, Damasceno DC, Salvadori DM, et al. Gene expression profile of whole blood cells differs in pregnant women with positive screening and negative diagnosis for gestational diabetes. BMJ Open Diabetes Res Care. 2016;4(1):e000273.
   PubMed Web of Science ®Google Scholar
• Brouillet S, Hoffmann P, Benharouga M, et al. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell. 2010;21(16):2832–2843.
   Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
   PubMed Web of Science ®Google Scholar
• Cetin I, Foidart JM, Miozzo M, et al. Fetal growth restriction: a workshop report. Placenta. 2004;25(8–9):753–757.
   PubMed Web of Science ®Google Scholar
• Brouillet S, Hoffmann P, Feige JJ, et al. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab. 2012;23(10):501–508.
   PubMed Web of Science ®Google Scholar
• Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762–1767.
   PubMed Web of Science ®Google Scholar
• Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn. 2002;22(9):778–782.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and risk of pre-eclampsia. Prenat Diagn. 2008;28(1):7–10.
   PubMed Web of Science ®Google Scholar
• Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452–1458.
   PubMed Web of Science ®Google Scholar
• Groom KM, McCowan LM, Stone PR, et al. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history – an open-label randomised trial (the EPPI trial): study protocol. BMC Pregnancy Childbirth. 2016;16(1):367.
   PubMed Web of Science ®Google Scholar
• Chiloiro M, Darconza G, Piccioli E, et al. Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol. 2001;36(8):538–543.
   PubMed Web of Science ®Google Scholar
• Wade PR, Palmer JM, Mabus J, et al. Prokineticin-1 evokes secretory and contractile activity in rat small intestine. Neurogastroenterol Motil. 2010;22(5):e152–e161.
   PubMed Web of Science ®Google Scholar
• Anderwald C, Tura A, Winhofer Y, et al. Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance test. Diabetes Care. 2011;34(7):1475–1480.
   PubMed Web of Science ®Google Scholar
• Pummara P, Tongsong T, Wanapirak C, et al. Association of first-trimester pregnancy-associated plasma protein A levels and idiopathic preterm delivery: a population-based screening study. Taiwan J Obstet Gynecol. 2016;55(1):72–75.
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Molina F, et al. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol. 2008;31(2):147–152.
   PubMed Web of Science ®Google Scholar